| Register for CBT’s FREE webinar June 6!  |
Mary Jane bought an eighth of Blue Dream. This cultivar has 23% total THC. She then rolls one half-gram joint. If she takes three puffs, how much THC, in milligrams, has she consumed?
That’s a tricky question, and it is the kind of complicated math required for customers and patients to truly understand how much THC they are consuming. Current labeling focusing on THC potency gives the wrong purchasing signals, propagating the THC-first buying trend that many industry professionals are trying to combat. Dr. Markus Roggen says there is a better way.
During Cannabis Business Times’ upcoming webinar June 6, Roggen, president and chief science officer of Delic Labs, a licensed cannabis and psychedelic R&D laboratory, will share findings that demonstrate that THC potency labeling isn’t only confusing—it’s miscalculated. He also will provide proposed solutions to clearly communicate THC levels to consumers—ideas borrowed from systems used in the nutraceutical and alcohol industries—in ways that could help craft the right sales message.
Don’t miss this FREE webinar and your opportunity to ask Dr. Roggen questions. | | |
|
|